Aβ conformational change is central to Alzheimer's disease

Neurobiology of Aging

Volumn 23, Issue 6, 2002, Pages 1085-1088

  Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; PEPTIDE; PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN; METAL;

ALZHEIMER DISEASE; BIOACCUMULATION; BLEEDING; BRAIN CIRCULATION; CELL DEATH; CELL LOSS; CELL PROLIFERATION; COGNITIVE DEFECT; GENE MUTATION; GLIOSIS; HUMAN; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIFESPAN; MICROGLIA; MUSCLE CELL; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; NOTE; ONSET AGE; PATHOGENESIS; PERIKARYON; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; AMYLOIDOSIS; ANIMAL; BRAIN; CHEMISTRY; CONFORMATION; FLOCCULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; BRAIN; FLOCCULATION; HUMANS; METALS; MICE; MICE, TRANSGENIC; MOLECULAR CONFORMATION; SENILE PLAQUES;

EID: 0036860357     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00040-4     Document Type: Note

References (28)

1. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M.et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:1997;263-264.
2. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S.et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 290:2000;2302-2303.
3. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R.E., Wyss-Coray T.et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe/Mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19:1999;4867-4880.
4. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged anti-nerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA. 97:2000;6826-6831.
5. Ertekin-Taner N., Graff-Radford N., Younkin L.H., Eckman C., Baker M., Adamson J.et al. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 290:2000;2303-2304.
6. Golde T.E., Eckman C.B., Younkin S.G. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;172-187.
7. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 293:2001;1491-1495.
8. Grabowski T.J., Cho H.S., Vonsattel J.P.G., Rebeck G.W., Greenberg S.M. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49:2001;697-705.
9. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90:1997;729-738.
10. Greenberg S.M., Rebeck G.W., Vonsattel J.P.G., Gomez-Isla T., Hyman B.T. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38:1995;254-259.
11. Guenette S.Y., Tanzi R.E. Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol. Aging. 20:1999;201-211.
12. Holtzman D.M. Role of apoE/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17:2001;147-155.
13. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J.et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;2892-2897.
14. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
15. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M.et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25:2001;402-405.
16. Li Y.-M., Xu M., Lai M.-T., Huang Q., Castro J.L., Dimuzio-Mower J.et al. Photoactivated-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 405:2000;689-694.
17. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
18. Morris J.C., Price J.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17:2001;101-118.
19. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D.et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 290:2000;2304-2305.
20. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C.et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4:2001;887-893.
21. Premkuman D.R.D., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148:1996;2083-2095.
22. Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases: the human illness and transgenic models. Science. 282:1998;1079-1083.
23. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKeel D.W., Morris J.C. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 58:2001;1395-1402.
24. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45:1999;358-368.
25. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
26. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19:1996;53-77.
27. Van Nostrand W.E., Melchor J.P., Soon Cho H., Greenberg S.M., Rebeck G.W. Pathogenic effects of D23N Iowa mutant amyloid-protein. J. Biol. Chem. 276:2001;32860-32866.
28. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999;513-517.